Novocure
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
💼Healthcare
👥1,001-5,000
📍Portsmouth
Novocure

About Novocure

Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.

Novocure news and updates

American Association for Cancer Research partnered with Novocure Ltd. on Nov 11th 19'.

Earlier this year, the American Association of Cancer Research (AACR) partnered with Novocure, a global oncology company, to launch several new funding initiatives to support innovative research focused on Tumor Treating Fields (TTFields).

Jan 1, 2019 | aacr.org

Novocure Ltd. launched 4 th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program on Dec 6th 21'.

NovoCure Ltd. (NASDAQ: NVCR) today announced the 4 th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program.

Jan 1, 2021 | biospace.com

Novocure Ltd. expands facilities to Portsmouth, New Hampshire, United States

Following suit, NovoCure announced that ground has been broken on a new facility in Portsmouth, New Hampshire.

Jan 1, 2022 | biospace.com

Novocure Ltd. hired Chris Sununu as Governor on Apr 19th 22'.

Today, Governor Chris Sununu (R-NH) joined Novocure for a ceremonial event commemorating the start of construction of its new flagship facility in the heart of downtown Portsmouth, New Hampshire.

Jan 1, 2022 | yahoo.com

xCures Inc. partnered with Novocure Ltd. on Jun 21st 22'.

[ EIN PressWire June 21, 2022 ] xCures, Inc., is proud to announce their partnership with Novocure with the intent to develop the first comprehensive, longitudinal Quality of Life (QoL) dataset for glioblastoma (GBM) patients.

Jan 1, 2022 | xcures.com

Novocure Ltd. went public on Jan 1st 15'.

NovoCure has maintained a large amount of institutional and insider investors since IPO in 2015.

Sep 7, 2022 | tradetoday.co.in

Novocure Ltd. launched U.S. CNS Cancers Franchise on Sep 21st 22'.

Novocure (NASDAQ: NVCR) today announced the creation of its U.S. CNS (central nervous system) Cancers Franchise.

Sep 21, 2022 | businesswire.com

Novocure Ltd. hires Frank Leonard as chief product officer

NovoCure named Frank Leonard, the company’s chief product officer, to lead the new effort.

Sep 23, 2022 | biospace.com

Novocure Ltd. promotes Ashley Cordova to chief financial officer

When Ashley Cordova was promoted to chief financial officer of the cancer treatment company Novocure Ltd., she was the only C-level executive there who was a woman.

Dec 5, 2022 | bloomberglaw.com
See More